Jeevan Scientific Technology Limited’s Post

Latest In Depth Pharma Industry News In case you missed it, PharmaCircle has been reporting on recent financial, regulatory and scientific developments impacting the pharmaceutical and device industries in our weekly newsletter and at The Weekly Brief: https://lnkd.in/eR7vAH3. Recent articles include: Kurt Sedo, Executive Editor and Cindy Dubin, Senior Editor at PharmaCircle looked at Pharma Industry Investment from 2019 through 2023. Their analysis based off of data from PharmaCircle's Business Intelligence Database shows that the number of VC investment was down more than 25% in 2023 compared to 2022 and 40% in 2023 compared to 2021. Cindy also looked at sales data tracked in PharmaCircle's Key Product Sales Module for the first 10 drugs being targeted by the U.S. Government's March-In policy. Kurt published a short report on the most common radioisotopes playing a key role in the $1 trillion personalized medicine market. These articles will be available for a couple more weeks at The Weekly Brief, and new articles are published each week. See what you’ve been missing - https://lnkd.in/eR7vAH3. Be the first to see new articles by signing up at https://lnkd.in/gsfCZ4VN. #VentureCapital #MarchIn #Radiopharmaceuticals #PersonalizedMedicine #pharmaceuticalindustry #pharmanews #PharmaCircle #TheWeeklyBrief

Healthcare Developments This Week: Breakthroughs in Medicine!The last week has been full of remarkable advancements in the healthcare sector, bringing hope and innovation to the forefront. Here's a quick update: Biocon Pharma's Big Win: Biocon Pharma has achieved a significant milestone with the USFDA's approval of its generic drug for Sacubitril/Valsartan tablets. This medication, used to treat chronic heart failure, is crucial for reducing the risk of death and hospitalization among adults. The approval covers various strengths, ensuring broader accessibility for patients in need. This approval not only solidifies Biocon’s position in the global pharmaceutical market but also contributes to the ongoing efforts to make life-saving drugs more accessible and affordable. With chronic heart failure being a leading cause of morbidity, this development is a vital step forward. #Healthcare #Pharmaceuticals #USFDA #Biotech #ChronicHeartFailure #InnovationInHealth

4th International Conference on Pharmaceutical and Healthcare: Lloyd #AIinhealthcare #Digitalhealth #Drugdiscovery #Healthcareanalytics #Healthcaretechnology #LloydInstitute #Personalizedmedicine #Pharmaceuticalinnovation #Sustainablehealthcare

4th International Conference on Pharmaceutical and Healthcare: Lloyd #AIinhealthcare #Digitalhealth #Drugdiscovery #Healthcareanalytics #Healthcaretechnology #LloydInstitute #Personalizedmedicine #Pharmaceuticalinnovation #Sustainablehealthcare

4th International Conference on Pharmaceutical and Healthcare: Lloyd #AIinhealthcare #Digitalhealth #Drugdiscovery #Healthcareanalytics #Healthcaretechnology #LloydInstitute #Personalizedmedicine #Pharmaceuticalinnovation #Sustainablehealthcare

4th International Conference on Pharmaceutical and Healthcare: Lloyd #AIinhealthcare #Digitalhealth #Drugdiscovery #Healthcareanalytics #Healthcaretechnology #LloydInstitute #Personalizedmedicine #Pharmaceuticalinnovation #Sustainablehealthcare

4th International Conference on Pharmaceutical and Healthcare: Lloyd #AIinhealthcare #Digitalhealth #Drugdiscovery #Healthcareanalytics #Healthcaretechnology #LloydInstitute #Personalizedmedicine #Pharmaceuticalinnovation #Sustainablehealthcare

Bonjour à tous👋, Je vous recommande de suivre notre dernier webinar sur l'analyse des Nitrosamines. Il est planifié le 14 novembre. Toutes les indications sont en dessous, il suffit simplement de cliquer sur le lien. Pharmaceutiquement 👋 💊 Corentin GENY ----------------------------------------------------------- 🔈Join us on November 14 for a virtual roundtable discussion on 𝗡𝗶𝘁𝗿𝗼𝘀𝗮𝗺𝗶𝗻𝗲 𝗔𝗻𝗮𝗹𝘆𝘀𝗶𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗣𝗵𝗮𝗿𝗺𝗮 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆. Register now to secure your spot: https://okt.to/EnXrke LGC Standards is sponsoring this exclusive webinar hosted by The Analytical Scientist, featuring top experts from AbbVie, Almac, and the FDA. Our distinguished panel will discuss critical topics, including: 1️⃣Overcoming the major challenges in detecting nitrosamines 2️⃣Current techniques and technologies 3️⃣How to build a robust method for nitrosamine analysis 4️⃣The impact of recent regulatory changes on the industry 5️⃣Future trends in nitrosamine testing and regulatory landscapes ⏲️November 14 | 10 am EST | 3 pm GMT Gain insights from leading voices in pharmaceutical analysis and stay ahead of the latest trends in nitrosamine testing. #NitrosamineTesting #PharmaceuticalAnalysis #pharmaindustry

𝐉𝐨𝐢𝐧 𝐭𝐡𝐞 𝐂𝐨𝐧𝐯𝐞𝐫𝐬𝐚𝐭𝐢𝐨𝐧 𝐚𝐭 𝐏𝐚𝐫𝐭𝐧𝐞𝐫𝐬𝐡𝐢𝐩 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝟐𝟎𝟐𝟒! The clinical trial landscape is evolving, and you’re invited to be at the forefront of this transformation! Mark your calendars for 𝐎𝐜𝐭𝐨𝐛𝐞𝐫 𝟐𝟗, 𝟐𝟎𝟐𝟒, and join us at the 𝐌ö𝐯𝐞𝐧𝐩𝐢𝐜𝐤 𝐇𝐨𝐭𝐞𝐥 𝐁𝐚𝐬𝐞𝐥 for 𝐏𝐚𝐫𝐭𝐧𝐞𝐫𝐬𝐡𝐢𝐩 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝟐𝟎𝟐𝟒 from 𝟏𝟏 𝐚.𝐦. 𝐭𝐨 𝟑 𝐩.𝐦. 𝐂𝐄𝐒𝐓. This exclusive event will feature insightful discussions on achieving a competitive edge through integrated CDMO and CRO services. Learn about cutting-edge technologies and strategies focused on patient-centricity in therapeutic development. Don’t miss this opportunity to network with peers and industry leaders, and gain valuable insights from 𝐓𝐡𝐞𝐫𝐦𝐨 𝐅𝐢𝐬𝐡𝐞𝐫 𝐒𝐜𝐢𝐞𝐧𝐭𝐢𝐟𝐢𝐜’𝐬 𝐥𝐚𝐭𝐞𝐬𝐭 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧𝐬 𝐚𝐧𝐝 𝐜𝐚𝐬𝐞 𝐬𝐭𝐮𝐝𝐢𝐞𝐬. Your voice matters as we navigate this dynamic landscape together! 👉 𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐍𝐨𝐰: https://lnkd.in/gtTxbb2N #PartnershipInsights2024 #CDMO #CRO #clinicaltrialinnovation #thermofisherscientific #biotech #pharmaceuticals #healthcareinnovation #networkingevent #patientfocus #futureofmedicine #baselevents #clinicalresearch #healthcaretrends #innovativesolutions #collaboratetoinnovate

4th International Conference on Pharmaceutical and Healthcare: Lloyd #AIinhealthcare #Digitalhealth #Drugdiscovery #Healthcareanalytics #Healthcaretechnology #LloydInstitute #Personalizedmedicine #Pharmaceuticalinnovation #Sustainablehealthcare